This is a working overview of mass spectrometry, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-04-02. Anything still debated is marked as such rather than presented as settled.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Analog of the tetrapeptide tuftsin |
| Sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Reported consistently across pharmacopoeial descriptions |
| Appearance | White to off-white lyophilized powder | Typical form of research-grade material |
| Solubility | Freely soluble in water | Aqueous buffers; poor in nonpolar solvents |
| Typical storage temperature | -20 degrees Celsius | Lyophilized powder; protect from moisture |
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Published clinical work is concentrated in Russian-language journals and generally involves small samples without independent replication. Systematic reviews in English note the shortage of randomised, placebo-controlled trials and the difficulty of verifying methods from translated reports. Outcome measures vary between studies, which complicates pooling of results. Interest in the compound as a cognitive or anxiolytic agent therefore rests on a thinner evidence base than the volume of citations suggests. Replication in well-powered trials with preregistered endpoints would be needed before firm conclusions about efficacy can be drawn.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Purity assessment relies mainly on reverse-phase high-performance liquid chromatography with ultraviolet detection. Because the peptide lacks a strong chromophore, detection often uses backbone absorbance near 214 nm. Identity is confirmed by mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, comparing the measured mass against the expected value. Amino acid analysis can verify composition after acid hydrolysis. Diastereomer content and residual counterions are reported less often, although both can influence biological assays.
Lyophilized material is generally stable for extended periods when kept dry at or below minus twenty degrees Celsius. Working solutions are less stable, and common practice is to aliquot and freeze them so that repeated freeze-thaw cycles are avoided. Aqueous solutions are sensitive to pH extremes and to microbial growth, so short-term storage at refrigerator temperature is typical. Oxidation and hydrolysis are the principal degradation routes. Reconstitution with sterile water or a mild buffer is standard, and solutions should be protected from light.
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
== Connective tissue-activating peptide III == Connective tissue-activating peptide III (CTAP-III), also called Low-affinity platelet factor IV (LA-PF4), is a protein that corresponds to positions 44-128 of PPBP. This protein has mitogenic effects: stimulating DNA synthesis and mitosis. It also triggers prostaglandin E2 secretion and synthesis of hyaluronic acid and sulfated glycosaminoglycan.
Portal was initially released in October 2007 as part of a compilation game called The Orange Box, alongside Half-Life 2 and its two episodes and Team Fortress 2. Valve considered including Portal as a bonus feature of the compilation; the game was purposely kept short such that if it did not meet expectations, players would have the rest of the content of The Orange Box as a "safety net". Portal has since been repackaged on Windows as a standalone game in April 2008. A Mac OS X client was introduced simultaneously with the release of the Steam client for that platform in May 2010; as part of its promotion, the game was released free of charge for both platforms during which at least 1.5 million players downloaded it.
=== General insulins === Insulins that are used mostly in humans are sometimes also used in animals such as cats and dogs. These include Lantus (insulin glargine), Novolin (NPH insulin), Humulin (NPH insulin), and Levemir (Detemir). It is of note that one of the listed insulins other than lente and PZI are FDA-approved for use in animals.
For some substances, such as carbon and arsenic, sublimation from solid state is much more achievable than evaporation from liquid state and it is difficult to obtain them as liquids. This is because the pressure of their triple point in its phase diagram (which corresponds to the lowest pressure at which the substance can exist as a liquid) is very high. Sublimation is caused by the absorption of heat which provides enough energy for some molecules to overcome the attractive forces of their neighbors and escape into the vapor phase. Since the process requires additional energy, sublimation is an endothermic change. The enthalpy of sublimation (also called heat of sublimation) can be calculated by adding the enthalpy of fusion and the enthalpy of vaporization.
==== Wagyu ==== Most of today's Wagyu are improved Wagyu (改良和牛, kairyō wagyū) that have been fixed as breeds through crossbreeding with foreign breeds. There are four breeds of improved Wagyu as follows:
Sources: en.wikipedia.org
Both sodium and potassium are commonly used as GRAS counterions to create more water-soluble and hence more bioavailable salt forms of acidic pharmaceuticals. Potassium compounds are often used as fertilisers as potassium is an important element for plant nutrition. Potassium hydroxide is a very strong base, and is used to control the pH of various substances. Potassium nitrate and potassium permanganate are often used as powerful oxidising agents. Potassium superoxide is used in breathing masks, as it reacts with carbon dioxide to give potassium carbonate and oxygen gas. Pure potassium metal is not often used, but its alloys with sodium may substitute for pure sodium in fast breeder nuclear reactors. Rubidium and caesium are often used in atomic clocks. Caesium atomic clocks are extraordinarily accurate; if a clock had been made at the time of the dinosaurs, it would be off by less than four seconds (after 80 million years). For that reason, caesium atoms are used as the definition of the second. Rubidium ions are often used in purple fireworks, and caesium is often used in drilling fluids in the petroleum industry. Francium has no commercial applications, but because of francium's relatively simple atomic structure, among other things, it has been used in spectroscopy experiments, leading to more information regarding energy levels and the coupling constants of the weak interaction. Studies on the light emitted by laser-trapped francium-210 ions have provided accurate data on transitions between atomic energy levels, similar to those predicted by quantum theory.
Now EC 1.14.14.46, pimeloyl-[acyl-carrier protein] synthase EC 1.14.15.13: pulcherriminic acid synthase EC 1.14.15.14: methyl-branched lipid ω-hydroxylase EC 1.14.15.15: cholestanetriol 26-monooxygenase EC 1.14.15.16: vitamin D3 24-hydroxylase EC 1.14.15.17: pheophorbide a oxygenase EC 1.14.15.18: calcidiol 1-monooxygenase EC 1.14.15.19: C-19 steroid 1α-hydroxylase EC 1.14.15.20: heme oxygenase (biliverdin-producing, ferredoxin) EC 1.14.15.21: zeaxanthin epoxidase EC 1.14.15.22: vitamin D 1,25-hydroxylase EC 1.14.15.23: chloroacetanilide N-alkylformylase EC 1.14.15.24: β-carotene 3-hydroxylase EC 1.14.15.25: p-cymene methyl-monooxygenase EC 1.14.15.26: toluene methyl-monooxygenase EC 1.14.15.27: β-dihydromenaquinone-9 ω-hydroxylase EC 1.14.15.28: cholest-4-en-3-one 26-monooxygenase [(25R)-3-oxocholest-4-en-26-oate forming] EC 1.14.15.29: cholest-4-en-3-one 26-monooxygenase [(25S)-3-oxocholest-4-en-26-oate forming] EC 1.14.15.30: 3-ketosteroid 9α-monooxygenase EC 1.14.15.31: 2-hydroxy-5-methyl-1-naphthoate 7-hydroxylase EC 1.14.15.32: pentalenene oxygenase EC 1.14.15.33: pikromycin synthase EC 1.14.15.34: 20-oxo-5-O-mycaminosyltylactone 23-monooxygenase EC 1.14.15.35: 6-deoxyerythronolide B hydroxylase EC 1.14.15.36: sterol 14α-demethylase (ferredoxin) EC 1.14.15.37: luteothin monooxygenase EC 1.14.15.38: N,N-dimethyl phenylurea N-demethylase EC 1.14.15.39: epi-isozizaene 5-monooxygenase
Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.
== References == Cinefantastique, Vol. 24, #6/Vol. 25, #1, February 1994 (special double-issue, with multiple articles on the Fox Network run). "Batman: The Animated Series Original Airdate and episode list". worldsfinestonline.com. Retrieved April 15, 2007. "Batman: The Animated Series Writers". Worldsfinestonline.com. Retrieved April 18, 2007. "Batman: The Animated Series Directors". Worldsfinestonline.com. Retrieved April 18, 2007. "Batman – Mask of the Phantasm". Worldsfinestonline.com. Retrieved April 18, 2007. "Batman & Mr. Freeze: Sub-Zero". Worldsfinestonline.com. Retrieved April 18, 2007. "Batman: The Animated Series Official Website". batmantas.com. Retrieved April 18, 2007.
Sources: en.wikipedia.org
They also stressed that the TWG had given too much credence to the chemistry experiments performed by the Russians, considered the TWG's retrospective treatment of the Russian work based on unpublished documents to have been "highly irregular", noted that there was no proof that 259Rf had a spontaneous fission branch at all (as of 2021 there still is not), and accused the TWG of not having appropriately qualified personnel on the committee. The TWG responded by saying that this was not the case and having assessed each point raised by the American group said that they found no reason to alter their conclusion regarding priority of discovery. The International Union of Pure and Applied Chemistry (IUPAC) adopted unnilquadium (Unq) as a temporary, systematic element name, derived from the Latin names for digits 1, 0, and 4. In 1994, IUPAC suggested a set of names for elements 104 through 109, in which dubnium (Db) became element 104 and rutherfordium became element 106. This recommendation was criticized by the American scientists for several reasons. Firstly, their suggestions were scrambled: the names rutherfordium and hahnium, originally suggested by Berkeley for elements 104 and 105, were respectively reassigned to elements 106 and 108. Secondly, elements 104 and 105 were given names favored by JINR, despite earlier recognition of LBL as an equal co-discoverer for both of them.
=== Generic names === Metenolone is the generic name of the drug and its INNTooltip International Nonproprietary Name, while methenolone is its BANTooltip British Approved Name. It has also been referred to as methylandrostenolone. This synonym should not be confused with methandrostenolone, which is another name for a different AAS known as metandienone.
Vice President Kamala Harris visits Guatemala, making it her first oversees trip as vice president. She urges migrants not to come to the United States–Mexico border. June 9 – President Biden visits the United Kingdom for the 2021 G7 summit, his first international trip as president. Biden also signs the New Atlantic Charter with British Prime Minister Boris Johnson, attends the 2021 Brussels summit with leaders of NATO countries, and meets with Russian President Vladimir Putin in Geneva, Switzerland the next week. June 10 – The Maine Legislature passes a law mandating the state government completely divest from fossil fuel by 2026. If signed into law, Maine will be the first state to divest from the fossil fuel industry. June 12 – COVID-19 misinformation: YouTube announces that it has suspended U.S. Senator Ron Johnson (R–WI) for violating their policies about promoting unproven alternative therapies to treat COVID-19. June 11–13 – List of mass shootings in the United States in 2021 – At least 10 people are killed and another 50 are injured in nine mass shootings in six states. June 14 American intelligence specialist Reality Winner, who was convicted in 2018 for leaking an NSA report on Russian interference in the 2016 United States elections to news site The Intercept, is released from prison. COVID-19 pandemic Hawaii reports their first case of the Lineage B.1.617 Delta variant in an Oahu resident who traveled to Nevada. Vermont Governor Phil Scott announces that 80% of individuals in his state have received a dose of the COVID-19 vaccine, becoming the first U.S.
Sources: en.wikipedia.org
Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.
The first four residues of Selank reproduce the tuftsin sequence Thr-Lys-Pro-Arg. A Pro-Gly-Pro extension at the C-terminus was added to slow enzymatic breakdown and extend residence time.
It holds marketing authorization in Russia, where nasal drop formulations are sold. No equivalent approval exists in the European Union, the United States, or most other countries.
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.